Medscape March 10, 2025
A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new research showed.
This risk-stratified algorithm led to an increase in the use of highly efficacious treatments (HETs), and a decrease in relapse rates, among Hispanic, Black, and White patients with MS.
“This study basically shows that if you give the good stuff to the people who need it, whether they’re Black, Hispanic, or White, you can get similar levels of disease control or improvement in their disease activity,” study investigator, Annette Langer-Gould, MD, PhD, regional lead for Clinical Translational Neuroscience, Kaiser Permanente Southern California (KPSC), Los Angeles, told Medscape Medical News.
The algorithm offers...
Today's Sponsors
Today's Sponsor